Authors:
LYRITIS GP
TSAKALAKOS N
PASPATI I
SKARANTAVOS G
GALANOS A
ANDROULAKIS C
Citation: Gp. Lyritis et al., THE EFFECT OF A MODIFIED ETIDRONATE CYCLICAL REGIMEN ON POSTMENOPAUSAL OSTEOPOROSIS - A 4-YEAR STUDY, Clinical rheumatology, 16(4), 1997, pp. 354-360
Authors:
LYRITIS GP
SKARANDAVOS G
PASPATI I
TSAKALAKOS N
Citation: Gp. Lyritis et al., THE EFFECT OF A MODIFIED ADFR THERAPEUTIC SCHEME (1,25-DIHYDROXYVITAMIN-D3, SALMON-CALCITONIN AND CALCIUM) ON ESTABLISHED OSTEOPOROSIS A 4-YEAR OPEN RANDOMIZED CONTROLLED-STUDY, Journal of bone and mineral research, 10, 1995, pp. 457-457
Citation: Gp. Lyritis et al., PREVENTION OF BONE LOSS IN EARLY NONSURGICAL AND NONOSTEOPOROTIC HIGHTURNOVER PATIENTS WITH SALMON-CALCITONIN - THE ROLE OF BIOCHEMICAL BONE MARKERS IN MONITORING HIGH TURNOVER PATIENTS UNDER CALCITONIN TREATMENT, Calcified tissue international, 56(1), 1995, pp. 38-41
Authors:
LYRITIS GP
ANDROULAKIS C
MAGIASIS B
CHARALAMBAKI Z
TSAKALAKOS N
Citation: Gp. Lyritis et al., EFFECT OF NANDROLONE DECANOATE ANS 1-ALPHA-HYDROXY-CALCIFEROL UPON PATIENTS WITH VERTEBRAL OSTEOPOROTIC COLLAPSE - A DOUBLE-BLIND CLINICAL-TRIAL, Calcified tissue international, 54(4), 1994, pp. 346-346
Authors:
LYRITIS GP
ANDROULAKIS C
MAGIASIS B
CHARALAMBAKI Z
TSAKALAKOS N
Citation: Gp. Lyritis et al., EFFECT OF NANDROLONE DECANOATE AND 1-ALPHA-HYDROXY-CALCIFEROL ON PATIENTS WITH VERTEBRAL OSTEOPOROTIC COLLAPSE - A DOUBLE-BLIND CLINICAL-TRIAL, Bone and mineral, 27(3), 1994, pp. 209-217
Authors:
TSAKALAKOS N
MAGIASIS B
TSEKOURA M
LYRITIS G
Citation: N. Tsakalakos et al., THE EFFECT OF SHORT-TERM CALCITONIN ADMINISTRATION ON BIOCHEMICAL BONE MARKERS IN PATIENTS WITH ACUTE IMMOBILIZATION FOLLOWING HIP FRACTURE, Osteoporosis international, 3(6), 1993, pp. 337-340